Patents by Inventor Pooja Gandhi

Pooja Gandhi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12257477
    Abstract: The controller of a wearable device is used to determine swim characteristics of a swimmer. The controller is connected to at least one motion sensor selected from a group including a multi-axis gyroscope and a multi-axis accelerometer. The controller is adapted to detect input signals from the at least one motion sensor. The controller is further configured to perform dynamic stroke segmentations based on at least one of the input signals using a stroke segmentation module, extract feature vectors, using feature extraction module, from the at least one input signal based on the stroke segmentations, and determine the swim characteristics by using the feature vectors through a classifier module. The controller dynamically adapts to a style of the swimmer to detect the swim characteristics.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: March 25, 2025
    Assignees: Robert Bosch GmbH, Robert Bosch Engineering and Business Solutions
    Inventors: Thorsten Sohnke, Amithash Kankanallu Jagadish, Kaustubh Ashok Gandhi, Sengottuvelan Senthilmurugan, Pudur Marudhachalam Dheepak, Mohan Pooja, Tomar Mahima
  • Publication number: 20210058739
    Abstract: A system for providing navigation services to a user in a volume of space can include a user device disposed in the volume of space, where the user device broadcasts, at a first time, at least one first communication signal into the volume of space, where the at least one first communication signal includes a first identification of the user and a destination of the user. The system can also include multiple electrical devices disposed in the volume of space, where each electrical device includes a transceiver, where the transceiver of a first subset of the electrical devices receives the at least one first communication signal broadcast by the user device, where the first subset of electrical devices sends a second communication signal based on the at least one first communication signal. The system can further include a controller communicably coupled to the plurality of electrical devices.
    Type: Application
    Filed: April 29, 2020
    Publication date: February 25, 2021
    Inventors: Ajinkya KULKAMI, Raksha Rao KARAYA, Aarathi RAMESH, Pooja GANDHI
  • Patent number: 10645532
    Abstract: A system for providing navigation services to a user in a volume of space can include a user device disposed in the volume of space, where the user device broadcasts, at a first time, at least one first communication signal into the volume of space, where the at least one first communication signal includes a first identification of the user and a destination of the user. The system can also include multiple electrical devices disposed in the volume of space, where each electrical device includes a transceiver, where the transceiver of a first subset of the electrical devices receives the at least one first communication signal broadcast by the user device, where the first subset of electrical devices sends a second communication signal based on the at least one first communication signal. The system can further include a controller communicably coupled to the plurality of electrical devices.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: May 5, 2020
    Assignee: Eaton Intelligent Power Limited
    Inventors: Ajinkya Kulkarni, Raksha Rao Karaya, Aarathi Ramesh, Pooja Gandhi
  • Patent number: 8722700
    Abstract: This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: May 13, 2014
    Assignee: Wyeth LLC
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi
  • Publication number: 20130252998
    Abstract: This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 26, 2013
    Applicant: Wyeth LLC
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi
  • Patent number: 8455539
    Abstract: This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: June 4, 2013
    Assignee: Wyeth LLC
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi
  • Patent number: 8299116
    Abstract: This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: October 30, 2012
    Assignee: Wyeth LLC
    Inventors: Joseph T Rubino, Victoria Siskavich, Maureen M Harrison, Pooja Gandhi
  • Publication number: 20110294845
    Abstract: This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 1, 2011
    Applicant: Wyeth LLC
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi
  • Patent number: 8026276
    Abstract: Parenteral formulations of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl) -2-methylpropionic acid (CCI-779) are provided. One parenteral formulation contains CCI-779, an alcoholic co-solvent, and an antioxidant. Another parenteral formulation contains CCI-779, an alcoholic solvent, an antioxidant, a diluent solvent, and a surfactant. Processes for preparing parenteral CCI-779 formulations using a co-solvent concentrate are also provided.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: September 27, 2011
    Assignee: Wyeth LLC
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi
  • Publication number: 20070142422
    Abstract: A method of preparing a rapamycin composition having increased potency is provided. The method involves selecting a rapamycin compound having less than 1.5% oxidative and hydrolytic rapamycin impurities and formulating the selected rapamycin with an antioxidant and optional excipients.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 21, 2007
    Applicant: Wyeth
    Inventors: Joseph Rubino, Pooja Gandhi, Lynn Phelan
  • Publication number: 20060251705
    Abstract: The present disclosure is directed to combination therapies of tigecycline and heparin and methods of administration of tigecycline and heparin.
    Type: Application
    Filed: May 5, 2006
    Publication date: November 9, 2006
    Applicant: Wyeth
    Inventors: Stephen Ludwig, Maja Vencl-Joncic, Pooja Gandhi, Joseph Gross, Julianna Koczone
  • Publication number: 20040167152
    Abstract: This invention provides parenteral formulations of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779).
    Type: Application
    Filed: July 25, 2003
    Publication date: August 26, 2004
    Applicant: Wyeth
    Inventors: Joseph T. Rubino, Victoria Siskavich, Maureen M. Harrison, Pooja Gandhi